ISPE conference content highlights supply chain

ISPE is offering content from its conference held earlier this month. Some speakers were recorded and the content is accessible as downloadable webinars. Content was also delivered virtually via live webcasts and live online speaker presentations.

One session, on global supply chain integrity and anti-counterfeiting, brought together industry leaders and FDA regulators to address concerns about maintaining a safe, efficacious drug supply, according to an announcement.

Amgen Vice President Martin VanTrieste, representing the newly formed Rx360 supply chain organization, was a presenter. He discussed geopolitical environmental scanning, a way "to detect, in advance, potential weaknesses in or disruptions to the supply chain that could lead to contamination, adulteration, or counterfeiting," according to a Pharmaceutical Technology magazine blog on the conference.

- see the ISPE selection of conference content
- review our earlier coverage of Rx360
- visit the PharmTech blog

Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.